Sherman F. Stinson

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

Adrian M. Senderowicz, Donna Headlee, Sherman F. Stinson et al. · Journal of Clinical Oncology · 1998 · 408 citations

Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts.

Francisco Arguello, Mark Alexander, Judith A. Sterry et al. · PubMed · 1998 · 242 citations

Antitumor Benzothiazoles. 8. Synthesis, Metabolic Formation, and Biological Properties of the <i>C</i>- and <i>N</i>-Oxidation Products of Antitumor 2-(4-Aminophenyl)benzothiazoles

Eiji Kashiyama, Ian Hutchinson, Mei‐Sze Chua et al. · Journal of Medicinal Chemistry · 1999 · 225 citations

13- <i>cis</i> -Retinoic Acid: Inhibition of Bladder Carcinogenesis Induced in Rats by <i>N</i> -Butyl- <i>N</i> -(4-hydroxybutyl)nitrosamine

Clinton J. Grubbs, Richard C. Moon, Robert A. Squire et al. · Science · 1977 · 111 citations

Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

Mei‐Sze Chua, Eiji Kashiyama, Tracey D. Bradshaw et al. · PubMed · 2000 · 102 citations

Medicinal Chemistry, Antitumor Properties, Breast Oncology +13